胰高血糖素样肽-1受体激动剂-话题@MedSci

#胰高血糖素样肽-1受体激动剂#

8篇内容 | 1382人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2236177, encodeId=32c322361e746, content=<a href='/topic/show?id=3ad9818917c' target=_blank style='color:#2F92EE;'>#肥胖#</a> <a href='/topic/show?id=d0fa98944c9' target=_blank style='color:#2F92EE;'>#青少年#</a> <a href='/topic/show?id=e8b584009c8' target=_blank style='color:#2F92EE;'>#胰高血糖素样肽-1受体激动剂#</a> <a href='/topic/show?id=0103862137f' target=_blank style='color:#2F92EE;'>#自杀意念#</a>, objectTitle=JAMA Pediatrics：GLP1受体激动剂治疗与肥胖青少年的自杀意念和自杀未遂风险降低有关, objectType=article, longId=850727, objectId=97d2850e275a, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20241110/1731217399613_5589937.jpg, objectUrl=/article/show_article.do?id=97d2850e275a, replyNumber=0, likeNumber=13, createdTime=2024-11-10, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=97d2850e275a, moduleTitle=JAMA Pediatrics：GLP1受体激动剂治疗与肥胖青少年的自杀意念和自杀未遂风险降低有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=97d2850e275a)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2216272, encodeId=cdf622162e2a0, content=<a href='/topic/show?id=2e6e6e0315d' target=_blank style='color:#2F92EE;'>#炎症性肠病#</a> <a href='/topic/show?id=e8b584009c8' target=_blank style='color:#2F92EE;'>#胰高血糖素样肽-1受体激动剂#</a>, objectTitle=APT：胰高血糖素样肽-1受体激动剂治疗2型糖尿病和炎症性肠病的结局, objectType=article, longId=835662, objectId=9de78356624c, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240722/1721632908109_92910.png, objectUrl=/article/show_article.do?id=9de78356624c, replyNumber=0, likeNumber=75, createdTime=2024-07-22, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=9de78356624c, moduleTitle=APT：胰高血糖素样肽-1受体激动剂治疗2型糖尿病和炎症性肠病的结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9de78356624c)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2214031, encodeId=87a7221403113, content=<a href='/topic/show?id=f3ad840081f' target=_blank style='color:#2F92EE;'>#胰高血糖素样肽-1#</a> <a href='/topic/show?id=6c6b5559ea5' target=_blank style='color:#2F92EE;'>#抗精神病药物#</a> <a href='/topic/show?id=e8b584009c8' target=_blank style='color:#2F92EE;'>#胰高血糖素样肽-1受体激动剂#</a>, objectTitle=Current Opinion in Psychiatry：GLP-1受体激动剂与精神分裂症中的减重效果, objectType=article, longId=833714, objectId=4179833e1497, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240709/1720492866217_92910.png, objectUrl=/article/show_article.do?id=4179833e1497, replyNumber=0, likeNumber=56, createdTime=2024-07-09, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=4179833e1497, moduleTitle=Current Opinion in Psychiatry：GLP-1受体激动剂与精神分裂症中的减重效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4179833e1497)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2175147, encodeId=e6d221e5147c9, content=<a href='/topic/show?id=ce9d239823b' target=_blank style='color:#2F92EE;'>#二甲双胍#</a> <a href='/topic/show?id=d20f1090c2' target=_blank style='color:#2F92EE;'>#2型糖尿病#</a> <a href='/topic/show?id=e8b584009c8' target=_blank style='color:#2F92EE;'>#胰高血糖素样肽-1受体激动剂#</a>, objectTitle=Front Endocrinol：10种胰高血糖素样肽-1受体激动剂加用二甲双胍治疗2型糖尿病患者的疗效和安全性比较, objectType=article, longId=805302, objectId=fd9580530202, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221115/1668550025111_4754896.jpeg, objectUrl=/article/show_article.do?id=fd9580530202, replyNumber=0, likeNumber=106, createdTime=2023-12-15, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=fd9580530202, moduleTitle=Front Endocrinol：10种胰高血糖素样肽-1受体激动剂加用二甲双胍治疗2型糖尿病患者的疗效和安全性比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fd9580530202)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1589249, encodeId=f84215892493b, content=<a href='/topic/show?id=e8b584009c8' target=_blank style='color:#2F92EE;'>#胰高血糖素样肽-1受体激动剂#</a>, objectTitle=2019 南亚工作组共识建议：应用胰高血糖素样肽-1受体激动剂 (GLP-1 RAs)治疗2型糖尿病, objectType=article, longId=176930, objectId=78571e6930a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=78571e6930a3, replyNumber=0, likeNumber=72, createdTime=2019-08-06, rootId=0, userName=hyf034, userId=c4bc17689294, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=78571e6930a3, moduleTitle=2019 南亚工作组共识建议：应用胰高血糖素样肽-1受体激动剂 (GLP-1 RAs)治疗2型糖尿病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=78571e6930a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1589248, encodeId=e87b1589248da, content=<a href='/topic/show?id=e8b584009c8' target=_blank style='color:#2F92EE;'>#胰高血糖素样肽-1受体激动剂#</a>, objectTitle=Diabetes Care.：胰高血糖素样肽-1受体激动剂是否增加糖尿病视网膜病变风险？, objectType=article, longId=159916, objectId=fef6159916b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fef6159916b0, replyNumber=0, likeNumber=71, createdTime=2019-02-15, rootId=0, userName=hyf034, userId=c4bc17689294, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fef6159916b0, moduleTitle=Diabetes Care.：胰高血糖素样肽-1受体激动剂是否增加糖尿病视网膜病变风险？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fef6159916b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1589247, encodeId=80aa158924ecb, content=<a href='/topic/show?id=e8b584009c8' target=_blank style='color:#2F92EE;'>#胰高血糖素样肽-1受体激动剂#</a>, objectTitle=JCEM：胰高血糖素样肽-1受体激动剂对下丘脑-垂体-肾上腺轴的影响, objectType=article, longId=150287, objectId=f97e15028ec4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f97e15028ec4, replyNumber=0, likeNumber=59, createdTime=2018-10-04, rootId=0, userName=hyf034, userId=c4bc17689294, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f97e15028ec4, moduleTitle=JCEM：胰高血糖素样肽-1受体激动剂对下丘脑-垂体-肾上腺轴的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f97e15028ec4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1589246, encodeId=9f5c158924626, content=<a href='/topic/show?id=e8b584009c8' target=_blank style='color:#2F92EE;'>#胰高血糖素样肽-1受体激动剂#</a>, objectTitle=2017 KDA立场声明：胰高血糖素样肽-1受体激动剂治疗2型糖尿病, objectType=article, longId=124605, objectId=82221246057a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=82221246057a, replyNumber=0, likeNumber=63, createdTime=2017-12-27, rootId=0, userName=hyf034, userId=c4bc17689294, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=82221246057a, moduleTitle=2017 KDA立场声明：胰高血糖素样肽-1受体激动剂治疗2型糖尿病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=82221246057a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1589245, encodeId=3cab1589245f6, content=<a href='/topic/show?id=e8b584009c8' target=_blank style='color:#2F92EE;'>#胰高血糖素样肽-1受体激动剂#</a>, objectTitle=Diabetes Obes Metab：胰高血糖素样肽-1受体激动剂治疗2型糖尿病的依从性和持久性, objectType=article, longId=103787, objectId=d625103e8766, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d625103e8766, replyNumber=0, likeNumber=98, createdTime=2017-06-30, rootId=0, userName=hyf034, userId=c4bc17689294, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d625103e8766, moduleTitle=Diabetes Obes Metab：胰高血糖素样肽-1受体激动剂治疗2型糖尿病的依从性和持久性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d625103e8766)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1589244, encodeId=a2631589244c8, content=<a href='/topic/show?id=e8b584009c8' target=_blank style='color:#2F92EE;'>#胰高血糖素样肽-1受体激动剂#</a>, objectTitle=胰高血糖素样肽-1受体激动剂研究进展, objectType=article, longId=73867, objectId=f2e1e386705, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f2e1e386705, replyNumber=0, likeNumber=84, createdTime=2016-07-29, rootId=0, userName=hyf034, userId=c4bc17689294, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f2e1e386705, moduleTitle=胰高血糖素样肽-1受体激动剂研究进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f2e1e386705)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1589243, encodeId=cb72158924349, content=<a href='/topic/show?id=e8b584009c8' target=_blank style='color:#2F92EE;'>#胰高血糖素样肽-1受体激动剂#</a>, objectTitle=Diabetes Obes Metab：胰高血糖素样肽-1受体激动剂治疗糖尿病的有效性和安全性荟萃分析, objectType=article, longId=61856, objectId=db2c6185660, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=db2c6185660, replyNumber=0, likeNumber=64, createdTime=2016-01-09, rootId=0, userName=hyf034, userId=c4bc17689294, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=db2c6185660, moduleTitle=Diabetes Obes Metab：胰高血糖素样肽-1受体激动剂治疗糖尿病的有效性和安全性荟萃分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=db2c6185660)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1589242, encodeId=cebf1589242eb, content=<a href='/topic/show?id=e8b584009c8' target=_blank style='color:#2F92EE;'>#胰高血糖素样肽-1受体激动剂#</a>, objectTitle=Circulation：新型降糖药胰高血糖素样肽-1受体激动剂的心脏保护作用, objectType=article, longId=36241, objectId=feee36241f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=feee36241f3, replyNumber=0, likeNumber=70, createdTime=2014-06-12, rootId=0, userName=hyf034, userId=c4bc17689294, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=feee36241f3, moduleTitle=Circulation：新型降糖药胰高血糖素样肽-1受体激动剂的心脏保护作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=feee36241f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

胰高血糖素样肽-1受体激动剂

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#肥胖# #青少年# #胰高血糖素样肽-1受体激动剂# #自杀意念#

JAMA Pediatrics：GLP1受体激动剂治疗与肥胖青少年的自杀意念和自杀未遂风险降低有关

2024-11-10发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#炎症性肠病# #胰高血糖素样肽-1受体激动剂#

APT：胰高血糖素样肽-1受体激动剂治疗2型糖尿病和炎症性肠病的结局

2024-07-22发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#胰高血糖素样肽-1# #抗精神病药物# #胰高血糖素样肽-1受体激动剂#

Current Opinion in Psychiatry：GLP-1受体激动剂与精神分裂症中的减重效果

2024-07-09发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#二甲双胍# #2型糖尿病# #胰高血糖素样肽-1受体激动剂#

Front Endocrinol：10种胰高血糖素样肽-1受体激动剂加用二甲双胍治疗2型糖尿病患者的疗效和安全性比较

2023-12-15发表于上海

hyf034 (审核中...)

前往app查看评论内容

#胰高血糖素样肽-1受体激动剂#

2019 南亚工作组共识建议：应用胰高血糖素样肽-1受体激动剂 (GLP-1 RAs)治疗2型糖尿病

2019-08-06

hyf034 (审核中...)

前往app查看评论内容

#胰高血糖素样肽-1受体激动剂#

Diabetes Care.：胰高血糖素样肽-1受体激动剂是否增加糖尿病视网膜病变风险？

2019-02-15

hyf034 (审核中...)

前往app查看评论内容

#胰高血糖素样肽-1受体激动剂#

JCEM：胰高血糖素样肽-1受体激动剂对下丘脑-垂体-肾上腺轴的影响

2018-10-04

hyf034 (审核中...)

前往app查看评论内容

#胰高血糖素样肽-1受体激动剂#

2017 KDA立场声明：胰高血糖素样肽-1受体激动剂治疗2型糖尿病

2017-12-27

hyf034 (审核中...)

前往app查看评论内容

#胰高血糖素样肽-1受体激动剂#

Diabetes Obes Metab：胰高血糖素样肽-1受体激动剂治疗2型糖尿病的依从性和持久性

2017-06-30

hyf034 (审核中...)

前往app查看评论内容

#胰高血糖素样肽-1受体激动剂#

胰高血糖素样肽-1受体激动剂研究进展

2016-07-29

hyf034 (审核中...)

前往app查看评论内容

#胰高血糖素样肽-1受体激动剂#

Diabetes Obes Metab：胰高血糖素样肽-1受体激动剂治疗糖尿病的有效性和安全性荟萃分析

2016-01-09

hyf034 (审核中...)

前往app查看评论内容

#胰高血糖素样肽-1受体激动剂#

Circulation：新型降糖药胰高血糖素样肽-1受体激动剂的心脏保护作用

2014-06-12

科室
- - 订阅+
  - 更多科室
工具
服务